College of Pharmacy Faculty

Dr. Scott Bragg completed undergraduate education and earned his PharmD degree from West Virginia University. He completed pharmacy residency training in family medicine at UPMC St. Margaret in Pittsburgh, Pennsylvania while completing a faculty development fellowship with the University of Pittsburgh Department of Family Medicine. Dr. Bragg joined the Medical University of South Carolina in 2013 and currently practices as a professor. His professional practice is in family medicine clinical pharmacy with the MUSC Health University Medical Center in Charleston, South Carolina where he provides clinical teaching to learners in pharmacy and medicine. Dr. Bragg’s professional interests are family medicine, teaching assessment, and evidence-based practice.

Katherine ‘Kathy’ Hammond Chessman, Pharm.D., FPPA, FCCP, BCNSP, was born in Greenville, SC. She graduated Magna Cum Laude with a Bachelor of Science in Biology from Presbyterian College and was selected as the Presbyterian College Outstanding Young Alumnus in 1997. Dr. Chessman received both a Bachelor of Science in Pharmacy and a Doctor of Pharmacy degree (Pharm.D.) from the College of Pharmacy at the Medical University of South Carolina (MUSC). She then completed her Pediatric Pharmacotherapy Residency with an emphasis in nutrition, pharmacokinetics, critical care, and research at the University of Tennessee and Le Bonheur Children’s Medical Center in Memphis, TN.

After finishing her residency program, Dr. Chessman accepted a position as the MUSC University Medical Center’s first, full-time, hospital-based clinical pharmacy specialist working in the Division of Pediatric Surgery. She is now chair of the Department of Clinical Pharmacy and Outcome Sciences and Professor with tenure at the MUSC College of Pharmacy, a clinical pharmacist specializing in pediatric surgery and intestinal rehabilitation at the MUSC Shawn Jenkins Children’s Hospital and previously served as director of the MUSC Pediatric Pharmacy Residency Program for 28 years.

At MUSC, Dr. Chessman served as president of the Faculty Senate and received one of the three inaugural university-wide MUSC Outstanding Clinician Awards (2000). She recently received the MUSC Commitment to Excellence in Interprofessional Education and Collaborative Practice Award. She is board-certified in nutrition support, previously board-certified in pharmacotherapy, a charter member of the Phi Lambda Sigma Leadership Society Beta Chi Chapter, and a fellow of the American College of Clinical Pharmacy (ACCP) and the Pediatric Pharmacy Association. She served on and chaired the Board of Pharmaceutical Specialties (BPS) Nutrition Support Council and the BPS Pediatric Pharmacy Specialty Council.

Dr. Chessman was the senior author on one of the first publications to describe using an ethanol lock to successfully reduce central line-related infections in children on home parenteral nutrition. She was also a member of the editorial boards of the ACCP’s Pharmacotherapy Self-Assessment Program 5th, 6th, and 7th Editions. She has authored several book chapters in the areas of fluids, electrolytes, nutrition, and various pediatric topics.

Dr. Drayton received her Pharm.D. degree from the University of South Carolina, College of Pharmacy in 2000. She then completed pharmacy practice and psychiatry specialty residencies at The Johns Hopkins Hospital in 2002 and 2003.

Dr. Drayton currently serves as Assistant Dean for Assessment and Accreditation and Associate Professor in the College of Pharmacy, Medical University of South Carolina. Board certified in Psychiatric Pharmacy Practice, her primary area of interest and research is in schizophrenia and mood disorders.

As an academician she was awarded the honor of 2011 SCCP, MUSC Preceptor of the Year and nominated for the MUSC Foundation Clinical Teaching Excellence Award. She was the featured leader for MUSC in the February 2015 edition of Focused Leadership, sponsored by ARROW (Advancement, Recruitment, and Retention of Woman). Dr. Drayton was named 2015 MUSC Foundation Educator-Lecturer of the Year. She also received the 2019-20 Academia Preceptor of the Year Award and 2021-22 Mentor of the Year Award.

Philip D. Hall, Pharm.D., FCCP, is professor and dean of the College of Pharmacy at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He received his Bachelor of Science in Pharmacy from the University of Georgia and Doctor of Pharmacy from the Medical College of Virginia (now Virginia Commonwealth University). He served as an oncology pharmacy resident at the Audie L. Murphy Veterans Administration Medical Center in San Antonio, Texas, and completed a fellowship in cancer immunotherapy research at the University of Texas Health Science in San Antonio and the University of Texas College of Pharmacy.

As an academician, Dr. Hall’s passion and commitment to pharmacy education is evident by his work at MUSC over the past 32 years. Since joining the faculty, he has risen from assistant professor to tenured professor and held multiple administrative roles with both the MUSC College of Pharmacy and South Carolina College of Pharmacy (SCCP). As associate dean and subsequently MUSC campus dean within the SCCP, he played a significant leadership role in developing the joint SCCP curriculum and program assessment while overseeing admissions and mentoring students. In 2016, he formally became dean of the MUSC College of Pharmacy upon its re-accreditation as an independent institution.

Board certified in both pharmacotherapy and oncology pharmacy, Dr. Hall is an accomplished writer, presenter, and researcher with over 120 publications, book chapters, & presentations. He is an acclaimed instructor, receiving a number of classroom and bedside teaching awards including professor/teacher/preceptor of the year 10 times and is a Fellow in the American College of Clinical Pharmacy.

Title: Associate Professor, Department of Clinical Pharmacy and Outcome Sciences; Ambulatory Care Clinical Pharmacy Specialist
Education: MUSC College of Pharmacy
Post-graduate training: PGY1 and PGY2 Critical Care at MUSC
Rotations offered: Advanced Heart Failure Clinic
haney@musc.edu

Assistant Professor and Clinical Pharmacy Specialist - Hematology/Oncology
Education: University of Georgia
Post-graduate training: PGY-1 Pharmacy Practice Residency & PGY-2 Oncology Pharmacy Specialty Residency, Grady Health System
Rotations offered: Ambulatory Care - Oncology, Academia
perand@musc.edu

Assistant Professor, Clinical Pharmacy and Outcome Sciences, MUSC College of Pharmacy
Clinical Pharmacy Specialist, Adult and Pediatric Infectious Diseases and Antimicrobial Stewardship, MUSC Health

Education: Wingate University School of Pharmacy
Post-graduate training: PGY-1 at Methodist University Hospital; PGY-2 Infectious Diseases at the University of Colorado; Postdoctoral Research Fellowship in Antimicrobial Pharmacokinetics/Pharmacodynamics and Infectious Diseases Health Outcomes at the Anti-Infective Research Laboratory at Wayne State University
Rotations offered: Adult and Pediatric Infectious Diseases/Antimicrobial Stewardship
tam271@musc.edu

Education: University of Utah
Post-graduate training: PGY1 and PGY2 Internal Medicine at MUSC
Rotations offered: Ambulatory Care Family Medicine
tran@musc.edu

Education: University of the Sciences in Philadelphia
Post-graduate training: PGY1 St. Thomas Hospital and University of Pittsburgh Medical Center
Rotations offered: Drug Information
ORCID Profile
wisniews@musc.edu

Education: University of Tennessee Health Sciences Center
Post-graduate training: PGY1 Residency at St. Thomas Hospital in Nashville, TN and PGY2 Trauma and Nutrition Specialty Residency at Regional One Medical Center in Memphis, TN
Rotations offered: Elective Academia
wisniewj@musc.edu

Dr. Hamann has published more than 265 peer-reviewed publications and book chapters primarily involving the characterization and pharmacology of new secondary metabolites from marine organisms with utility as drug leads for the control of cancer. His is one of the few labs in the world that has taken new molecules all the way from discovery into clinical studies for the control of cancer. The Hamann Lab routinely uses NMR and MS studies to characterize complex peptides, polyketides, and alkaloids from a diversity of phylogenetic groups including dinoflagellates, bacteria, fungi, macroalgae, marine invertebrates, and plants.

I have a long-standing interest in the role of mitochondrial metabolism in pathobiology, especially in relation to alcoholic and non-alcoholic steatohepatitis, oxidative stress, ischemia-reperfusion injury to heart and liver, mitochondrial autophagy (mitophagy), and cancer. My laboratory has published more than 400 papers in peer-reviewed journals (h-index = 118) plus more than 100 book chapters. Productive, long-term collaborations with junior and senior colleagues contributed importantly to this success. For these projects, my laboratory applies new techniques of quantitative laser scanning confocal, intravital multiphoton, and super-resolution microscopy, as well as Seahorse respirometry and related metabolic flux techniques, for physiological analysis of mitochondria and other organelles in living cells and in the intact tissues of living animals.

I have a long-standing interest in research related to mechanisms of mitochondrial dysfunction employing various models of oxidative stress, photodynamic therapy, sensitization of pancreatic cancer to conventional chemotherapy, and applying nanoparticles to treat head and neck cancers. My role is to serve as a Senior Imaging Specialist of the Cell & Molecular Imaging (CMI) Shared Resource.  I share responsibility for facility oversight and ensure that the facility continues to provide high quality biological imaging of quantitative laser scanning confocal, intravital multiphoton and super-resolution microscopy, and maintains a sound business plan. When needed, I advise the users on their experiments. I also participate in planning and teaching at a biennial one-week Charleston Workshop on Light Microscopy for the Biosciences that provides training in the principles of different optical imaging modalities, as well as extensive hands-on training with state-of-the-art equipment at the MUSC.

My research focus is to employ in vitro, cell-based, and in silico approaches to quantitate protein and small molecule functionality as a bridge between chemical biology and pathobiology. My training and background is in cell and molecular pharmacology, cancer biology and informatics, chemical biology, and biotechnology.

My expertise in bioassays, microscopy, high-throughput screening, protein-ligand and protein-protein interactions and cheminformatics have contributed in a number of biologic signaling systems.

My research interest includes both basic and translational research on hepatology and toxicology, especially on the roles of free radicals and mitochondrial dysfunction in liver injury, inflammation and fibrosis. I have long-lasting interest in pathogenesis of alcohol-associated and non-alcoholic fatty liver diseases and liver fibrosis. I am also interested in the mechanisms by which hepatic steatosis exacerbates hepatic ischemia/reperfusion injury. I have substantial hands-on experience in induction of fatty livers by dietary and alcohol treatment and familiar with many techniques that are needed for these studies, e.g., in vivo gene delivery by viral vectors, liver pathology, immunohistochemistry, and fluorescent, electron, and confocal/multiphoton microscopy.